cathepsin K inhibitors (Taiho)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecathepsin K inhibitors (Taiho)
Drug Alias NameCLIK-166CLIK-164CLIK-163CLIK-162
ClassificationSmall molecules
Mechanisms of ActionBone modulatorsCathepsin K inhibitors
TargetsCathepsin K
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaiho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A